Efficacy and safety of hydro-mechanical defragmentation in intermediate- and high-risk pulmonary embolism.

ABSTRACT:

Background

Pulmonary embolism (PE) is the third most common acute cardiovascular syndrome. Percutaneous catheter directed hydro-mechanical defragmentation (HMD) is one of the recommended treatment options for PE in patients with contraindications to thrombolytic therapy or failed systemic thrombolysis (ST). We aimed to identify the safety and outcomes of catheter directed HMD in patients with high-risk PE. This nonrandomized controlled trial enrolled all patients with confirmed diagnoses of high- and intermediate-high-risk PE from October 2019 till January 2021. Fifty patients were included and divided into two groups by the PE response team according to the presence or absence of a contraindication for ST. Group B (ST) consists of 25 patients and group A (HMD) of 25 patients who c

SUBMITTER: Hassan AKM 

PROVIDER: S-EPMC8464550 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature